Search clinical trials for: MEMO Patch PLUS for More than 8-days

Total 18 results

Yonsei University

Not yet recruiting

A Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of Stroke (MEMO-DAF8)

Atrial Fibrillation/Flutter in Patients With High Risk of Stroke

Korea, Republic of
Abdelrady S Ibrahim, MD
Assiut University

Completed

The Effect of Red Blood Cells Storage Duration on Biochemical Changes in Pediatric Patients

Red Blood Cells Transfusion

Egypt
Istanbul Medipol University Hospital

Not yet recruiting

Effectiveness of High Intensity Electromagnetic Therapy and Pelvic Floor Exercises in Women With Urinary Incontinence

Urinary Incontinence
Bozyaka Training and Research Hospital

Completed

Effects of Preoperative Fasting on ECG and Vital Parameters

Ischemia | Intraoperative Complications | Fasting

Turkey
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; Brown University; University of Southern California; Weill... and other collaborators

Recruiting

Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study

Breast Cancer | Rare Cancer

United States
Central Hospital, Nancy, France

Completed

Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation (TIH ECMO)

Heparin-induced Thrombocytopenia
Pfizer

Completed

Study to Assess Pharmacokinetics, Safety and Tolerability of PF-04965842 in Chinese Healthy Participants

HEALTHY

China
Sun Yat-sen University

Recruiting

Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer

Triple Negative Breast Cancer

China
Memorial Sloan Kettering Cancer Center
GlaxoSmithKline; University of Washington

Completed

Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer

Prostate Cancer | Castration-resistant, Metastatic

United States
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Aripiprazole Effects on Alcohol Reactivity and Consumption

Alcohol Dependence

United States
Gilead Sciences

Completed

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection

Hepatitis C

United States, Puerto Rico
Memorial Sloan Kettering Cancer Center
Tufts Medical Center; Lahey Clinic

Completed

Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L

Multiple Myeloma

United States
Scott and White Hospital & Clinic
Organon

Completed

Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

Breakthrough Bleeding | Breakthrough Spotting

United States
Memorial Sloan Kettering Cancer Center

Completed

Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma (PCNSL)

Non-Hodgkin's Lymphoma | CNS Lymphoma | CNS Brain Cancer

United States
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Villa Gaiato, Modena; Ospedale Regionale di Locarno

Terminated

Non-Invasive Mechanical Ventilation in Elderly Patients

Acute Respiratory Failure

Italy
University of Washington

Recruiting

Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma

Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 3b Follicular Lymphoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Recurrent Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Refractory Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Lymphoma | Clonal Cytopenia of Undetermined Significance | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements

United States
National Cancer Institute (NCI)

Active, not recruiting

Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Ganglioneuroblastoma | High Risk Neuroblastoma

United States, New Zealand, Australia

Search clinical trials for: MEMO Patch PLUS for More than 8-days

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations